FDA Safety Alerts: Understanding Generic Drug Risks and Labeling Gaps
Explore how FDA safety alerts handle generic drug risks, the labeling gaps caused by the Hatch-Waxman Act, and the ongoing debate over the CBE-0 process for faster warning updates.
